Halladay Benjamin sold ESPR
September 17, 2025 · Form 4 insider transaction
Halladay Benjamin sold 7,046 shares of Esperion Therapeutics, Inc. Common Stock at $2.81 per share, a transaction worth $19.8K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
7,046
Price
$2.81
Total value
$19.8K
InsiderHalladay Benjamin
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateSeptember 17, 2025
Filing dateSeptember 18, 2025
Shares owned after474,862
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Shares were sold to satisfy tax obligation on vested shares of restricted stock units.; Includes 7,446 shares recently acquired in Esperion's Employee Stock Purchase Plan.